Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zhejiang Huahai Pharmaceutical Co., Ltd.

http://en.huahaipharm.com

Latest From Zhejiang Huahai Pharmaceutical Co., Ltd.

China Refuses Paxlovid Coverage Beyond March, Despite Strong Demand

China has rejected extending insurance coverage for Pfizer’s Paxlovid despite the US company's plans to continue supplying the oral COVID-19 antiviral, including through local manufacturing, amid strong demand and increasing severe infections in the country.

China Coronavirus COVID-19

A Year Of Paxlovid - Where Is The Licensed Generic?

A year since Paxlovid was launched and The Medicines Patent Pool licensed Pfizer’s nirmatrelvir, we look at a few likely reasons for authorized generics of Paxlovid not turning up and what lies ahead in 2023, as Hetero’s version becomes the first with WHO prequalification while two Chinese and a Korean company wait in the wings.

Coronavirus COVID-19 Generic Drugs

A Year Of Paxlovid - Where Is The Licensed Generic?

It’s been a year since Paxlovid was launched and The Medicines Patent Pool licensed Pfizer’s nirmatrelvir. Scrip looks at a few likely reasons for authorized generics of Paxlovid not turning up and what lies ahead in 2023 as Hetero's version becomes the first with WHO Prequalification while two Chinese and a Korean company wait in the wings.

Commercial Coronavirus COVID-19

TCMs Not Paxlovid Gain Traction As Beijing On High Alert

As Shanghai enters a second week of a city-wide lockdown with no signs of policy easing, officials are promoting the use of traditional Chinese medicines rather than Pfizer's recently approved Paxlovid.

China Coronavirus COVID-19
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Other Names / Subsidiaries
    • Huabo Biopharm Co., Ltd.
UsernamePublicRestriction

Register